Literature DB >> 11734665

Haemostasis in ischaemic stroke and vascular dementia.

D J Stott1, E Spilg, A M Campbell, A Rumley, M A Mansoor, G D Lowe.   

Abstract

Abnormalities of coagulation and fibrinolysis may play an important role in the pathogenesis of ischaemic stroke and vascular dementia. We aimed to determine whether haemostatic function is altered in acute recent-onset or chronic ischaemic cerebrovascular disease. We studied consecutive patients with ischaemic stroke (n = 74) and vascular dementia (n = 42) compared with healthy controls (n = 40) in a case-control study. The ischaemic stroke group was assessed twice, 3-10 days after the acute stroke and at 1-3 months. Fibrinogen, fibrin D-dimer (marker of fibrin turnover) and von Willebrand factor (vWF) (marker of endothelial disturbance) were elevated acutely (P < 0.0001) and in the convalescent phase after ischaemic stroke (P < 0.0001, P < 0.0001, and P < 0.01 respectively, compared with controls). Similar results were seen in the vascular dementia group. Stepwise multivariate regression analyses showed that cerebrovascular disease correlated independently with fibrinogen (P < 0.001) and fibrin D-dimer levels (P < 0.001), while vWF correlated independently with electrocardiograph evidence of ischaemic heart disease (P = 0.004). Changes between acute and convalescent phases in ischaemic stroke were slightly inconsistent. However, in the acute stage there were tendencies for fibrinogen, D-dimer and vWF to be increased, and factor VIII was significantly higher. Abnormalities of haemostasis, including increased fibrin turnover and endothelial disturbance, are found in both acute and chronic cerebral ischaemia. Many of these patients have co-existent ischaemic heart disease and this may contribute to some of these changes. Acute ischaemic stroke is associated with transient changes in haemostatic factors; however, most abnormalities persist into the convalescent phase, and are also demonstrable in subjects with vascular dementia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11734665     DOI: 10.1097/00001721-200112000-00006

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  11 in total

1.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

Review 2.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

Review 3.  von Willebrand factor: an emerging target in stroke therapy.

Authors:  Simon F De Meyer; Guido Stoll; Denisa D Wagner; Christoph Kleinschnitz
Journal:  Stroke       Date:  2011-12-15       Impact factor: 7.914

4.  Bioinformatic identification and characterization of human endothelial cell-restricted genes.

Authors:  Manoj Bhasin; Lei Yuan; Derin B Keskin; Hasan H Otu; Towia A Libermann; Peter Oettgen
Journal:  BMC Genomics       Date:  2010-05-28       Impact factor: 3.969

5.  Air quality improvement during 2010 Asian games on blood coagulability in COPD patients.

Authors:  Zili Zhang; Jian Wang; Meihua Guo; Mingmei Xiong; Qipeng Zhou; Defu Li; Jiaze Shu; Wenju Lu; Dejun Sun
Journal:  Environ Sci Pollut Res Int       Date:  2015-12-09       Impact factor: 4.223

6.  ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort.

Authors:  Kristine S Alexander; Neil A Zakai; Sarah Gillett; Leslie A McClure; Virginia Wadley; Fred Unverzagt; Mary Cushman
Journal:  Neurology       Date:  2014-09-10       Impact factor: 9.910

Review 7.  Cognitive function, dementia and type 2 diabetes mellitus in the elderly.

Authors:  Mark W J Strachan; Rebecca M Reynolds; Riccardo E Marioni; Jacqueline F Price
Journal:  Nat Rev Endocrinol       Date:  2011-02       Impact factor: 43.330

8.  Reduced cognitive function, increased blood-brain-barrier transport and inflammatory responses, and altered brain metabolites in LDLr -/-and C57BL/6 mice fed a western diet.

Authors:  Jennifer M Rutkowsky; Linda L Lee; Michelle Puchowicz; Mari S Golub; Douglas E Befroy; Dennis W Wilson; Steven Anderson; Gary Cline; Jason Bini; Kamil Borkowski; Trina A Knotts; John C Rutledge
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

9.  Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.

Authors:  Joung Wook Lee; Hong Namkoong; Hyun Kee Kim; Sanghee Kim; Dong Whi Hwang; Hae Ri Na; Seon-Ah Ha; Jae-Ryong Kim; Jin Woo Kim
Journal:  BMC Neurol       Date:  2007-06-12       Impact factor: 2.474

10.  Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study.

Authors:  Soo Chan Carusone; Marek Smieja; William Molloy; Charlie H Goldsmith; Jim Mahony; Max Chernesky; Judy Gnarpe; Tim Standish; Stephanie Smith; Mark Loeb
Journal:  BMC Neurol       Date:  2004-10-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.